How to Get Lisinopril in South Dakota

Prescription access and medication affordability image for How to Get Lisinopril in South Dakota

At a glance

  • Drug class / ACE inhibitor, oral tablet
  • Typical starting dose / 10 mg once daily for hypertension
  • Telehealth prescribing in SD / Yes, fully legal
  • Standard labs before starting / BMP (creatinine, potassium, eGFR)
  • South Dakota Medicaid coverage / Not covered as of 2025
  • Mail-order pharmacy shipping to SD / Available statewide
  • 503A compounding in SD / Yes, licensed 503A pharmacies may ship
  • Time from consult to first dose / 2 to 5 business days
  • Who can prescribe / MD, DO, NP, PA (all licensed in SD)
  • Generic retail cost / $4 to $15/month at major chains

What Is Lisinopril and Why Is It Prescribed?

Lisinopril is an ACE (angiotensin-converting enzyme) inhibitor approved by the FDA for hypertension, heart failure, and left-ventricular dysfunction after myocardial infarction, as well as nephropathy in type 1 diabetes. The FDA prescribing label lists once-daily oral dosing with a typical antihypertensive starting dose of 10 mg and a maximum of 40 mg per day.

The drug blocks the conversion of angiotensin I to angiotensin II, reducing vasoconstriction and aldosterone secretion. Blood pressure response begins within one hour of the first dose, with peak effect at six to eight hours and a 24-hour duration that supports once-daily dosing. [1]

Beyond blood pressure, the ALLHAT trial (N=33,357, JAMA 2002) compared lisinopril with chlorthalidone and amlodipine across high-risk hypertensive adults and found that lisinopril produced a six-year combined fatal CHD and nonfatal MI rate of 11.4%, statistically comparable to the chlorthalidone arm (11.5%, P<0.001 for non-inferiority), confirming ACE inhibitors as first-line therapy in diverse patient populations. [2]

For patients with chronic kidney disease (CKD) and proteinuria, the REIN-2 trial (Lancet 2005) showed that intensive blood pressure control with an ACE inhibitor slowed GFR decline by roughly 30% versus standard control over 36 months. [3] That makes lisinopril one of the few antihypertensives with a direct nephroprotective mechanism supported by dedicated renal-endpoint data.

Generic lisinopril has been available in the United States since the early 2000s, and it now ranks among the five most commonly prescribed medications in the country according to CDC prescribing surveillance data. [4]


Is Lisinopril Available Through Telehealth in South Dakota?

Yes. South Dakota authorizes telehealth prescribing of lisinopril, and a licensed provider who holds a South Dakota DEA registration (or a state-controlled-substance certificate, though lisinopril is not a controlled substance) may issue a new prescription through a synchronous audio-video visit. No special telehealth waiver is required for non-controlled medications under South Dakota Codified Laws Chapter 36-4.

The South Dakota Board of Medical Examiners requires that the prescribing relationship include a sufficient evaluation to establish a diagnosis. For lisinopril, that evaluation typically covers blood pressure readings (at least two separate readings), relevant medical history (diabetes, CKD, prior cardiovascular events), and a review of contraindications such as bilateral renal artery stenosis or a history of ACE-inhibitor-induced angioedema.

Telehealth platforms that operate in South Dakota generally follow a three-step workflow: (1) asynchronous intake form completed by the patient, (2) synchronous video or telephone visit with a licensed SD provider, and (3) electronic prescription sent directly to the patient's preferred pharmacy or a mail-order partner. Most platforms complete steps one and two within 24 to 48 hours of booking. [5]

The American Heart Association 2023 hypertension guideline states: "Telehealth-based monitoring and medication management are effective strategies for improving blood pressure control, particularly in rural and underserved populations." South Dakota has substantial rural geography, with roughly 43% of the state's population living outside metropolitan statistical areas according to the U.S. Census Bureau, making telehealth access especially relevant.

HealthRX Telehealth Prescribing Framework for Lisinopril in SD:

| Step | Action | Typical timeline | |------|--------|-----------------| | 1. Intake | Complete symptom and history form | Day 1 (15 min) | | 2. Lab order (if no recent BMP) | eGFR, creatinine, potassium | Days 1 to 3 | | 3. Clinician visit | Synchronous video consult | Day 2 to 4 | | 4. Rx transmission | Electronic to pharmacy of choice | Same day as visit | | 5. Dispensing | Retail same-day or mail-order 2 to 3 days | Days 2 to 5 | | 6. Follow-up labs | Repeat BMP at 2 to 4 weeks | Week 2 to 4 |


What Labs Are Required Before Starting Lisinopril in South Dakota?

A basic metabolic panel (BMP) covering serum creatinine, estimated glomerular filtration rate (eGFR), potassium, and sodium is the standard pre-treatment laboratory assessment. Most prescribers also obtain a urinalysis with spot urine albumin-to-creatinine ratio if CKD or diabetic nephropathy is suspected.

The rationale is straightforward. ACE inhibitors reduce angiotensin-II-driven efferent arteriole constriction, which can transiently reduce GFR in patients with pre-existing renal insufficiency. A baseline creatinine above 2.5 mg/dL or an eGFR below 30 mL/min/1.73m² warrants specialist co-management rather than outpatient initiation without nephrologist input. [6]

Potassium monitoring matters because ACE inhibitors reduce aldosterone secretion, raising serum potassium by an average of 0.1 to 0.2 mEq/L in patients with normal renal function. That number climbs to 0.5 to 1.0 mEq/L in moderate CKD. Baseline potassium above 5.0 mEq/L is a relative contraindication at most clinical thresholds. [7]

A repeat BMP at two to four weeks after initiation is the standard follow-up interval recommended by JNC guidelines and reflected in the 2023 AHA/ACC Hypertension Guideline. [8] A creatinine rise of up to 30% from baseline within the first two weeks is considered acceptable and does not require discontinuation; rises beyond 30% require clinical reassessment.

Pregnancy testing is indicated for women of reproductive age, as lisinopril is FDA Pregnancy Category D (second and third trimester) with Black Box Warning for fetal injury and death. [1]


Who Can Prescribe Lisinopril in South Dakota?

Four provider types hold independent or delegated prescribing authority for lisinopril in South Dakota.

Medical doctors (MD) and doctors of osteopathic medicine (DO) hold full independent prescribing authority under SDCL 36-4. No quantity or drug-class restriction applies to non-controlled medications.

Nurse practitioners (NPs) in South Dakota hold full practice authority as of 2021 under SDCL 36-9A. They may prescribe, dispense, and administer medications including lisinopril without physician oversight or a collaborative practice agreement for Schedule III through V controlled substances. Non-controlled medications like lisinopril carry no additional restriction.

Physician assistants (PAs) prescribe under delegated authority per SDCL 36-4A. Their supervising physician must be licensed in South Dakota, but the delegation agreement routinely covers all non-controlled medications. A PA employed by a telehealth practice with a supervising SD-licensed physician may therefore prescribe lisinopril to South Dakota patients.

Pharmacist prescribing under collaborative practice protocols exists in some health systems in South Dakota, primarily for hypertension management programs, though this is not universally available outside hospital or clinic-embedded settings.

The practical takeaway: most telehealth platforms operating in South Dakota use NPs or PAs as their primary prescribers for straightforward hypertension management, given their full non-controlled prescribing authority and shorter scheduling lead times.


How Long Does It Take to Receive Lisinopril in South Dakota?

From the time of booking a telehealth consult to having the medication in hand, South Dakota patients typically wait two to five business days, depending on whether baseline labs are required and which pharmacy is used.

Patients with a recent BMP (within the past 60 days) can often complete a telehealth visit and have an electronic prescription sent to a local retail pharmacy within 24 to 48 hours of scheduling. Walgreens, CVS, and Hy-Vee Pharmacy locations across Sioux Falls, Rapid City, Aberdeen, and Brookings generally fill same-day or next-day. Independent pharmacies in smaller communities (Huron, Watertown, Pierre, Spearfish) operate similarly.

Mail-order pharmacies such as Express Scripts, OptumRx, and Amazon Pharmacy ship to all South Dakota ZIP codes, with standard delivery in two to four business days and expedited shipping available in one to two days. Many of these services offer 90-day supplies of generic lisinopril for $10 to $30, significantly below the $4 to $15/month cost at retail chains.

Patients without recent labs face a longer path. At-home lab kits (finger-stick BMP panels shipped by services such as Labcorp OnDemand) can return results in one to three business days, adding time before the prescribing visit occurs. Some telehealth platforms allow the consult to proceed with a conditional prescription held until labs return within a specified range.


Can You Transfer a Lisinopril Prescription to South Dakota?

Yes, with qualifications. South Dakota pharmacy law follows the Uniform Prescription Drug Act provisions that allow transfer of remaining refills between licensed pharmacies within the state and across state lines for non-controlled substances. Lisinopril is not a controlled substance, so no DEA transfer restrictions apply.

To transfer an existing prescription, the patient needs only to contact the receiving South Dakota pharmacy with the name and phone number of the originating pharmacy. The pharmacies coordinate directly. Electronic transfers through shared pharmacy networks (Walgreens-to-Walgreens, CVS-to-CVS) often complete within minutes. Cross-chain transfers require a pharmacist-to-pharmacist fax or electronic record exchange and may take one business day.

One point to watch: if the original prescription was written by an out-of-state provider who is not licensed in South Dakota, the prescription itself remains valid for filling in South Dakota as long as the prescriber held a valid license in the state where it was written. South Dakota pharmacists may fill prescriptions from out-of-state licensed practitioners under SDCL 36-11. [9]

If the prescription is expired (beyond one year from the write date in most states), the patient needs a new prescription from either their original provider (via telehealth if the provider is licensed in SD or the patient returns to their home state) or from a new South Dakota-licensed provider.


Are 503A Pharmacies Licensed to Ship Lisinopril to South Dakota?

Yes. A 503A compounding pharmacy licensed in South Dakota, or licensed in another state and registered to ship into South Dakota, may compound and dispense lisinopril in non-commercially available dose forms (such as a liquid suspension for patients who cannot swallow tablets) when prescribed for an identified patient. This pathway is most commonly used for pediatric patients or adults with dysphagia.

The FDA's guidance on 503A compounding pharmacies distinguishes between patient-specific 503A pharmacies and large-scale 503B outsourcing facilities. Lisinopril in a commercially available strength (2.5 mg, 5 mg, 10 mg, 20 mg, 40 mg tablets) should not be compounded when a commercially manufactured equivalent is readily available, per the FDA's current enforcement policy. [10] Compounding is appropriate when a patient requires an alternative dose form or a strength not stocked by any manufacturer.

South Dakota's Board of Pharmacy oversees 503A licensure. Patients who receive compounded lisinopril from an out-of-state pharmacy should verify that the pharmacy holds an active non-resident pharmacy license issued by the South Dakota Board of Pharmacy before accepting a shipment.


What Does Prior Authorization Require in South Dakota?

South Dakota Medicaid does not currently cover lisinopril, so prior authorization (PA) through Medicaid is moot for most patients on public insurance. However, commercial insurance plans (Sanford Health Plan, Wellmark BCBS, Avera Health Plans, UnitedHealthcare) sold in South Dakota may require prior authorization for brand-name ACE inhibitors or specific dose strengths if generic alternatives are available at a lower tier.

For generic lisinopril specifically, PA is rarely required on commercial formularies because the drug sits at Tier 1 on nearly all standard formularies at a $0 to $10 copay. Where PA does appear, it typically arises for:

  1. Doses above 40 mg/day (above the FDA-labeled maximum)
  2. Use in off-label indications not recognized by the plan's medical policy
  3. Step-therapy requirements demanding proof of prior ACE-inhibitor trial before approving an ARB, where the insurer wants documentation that lisinopril was tried first

The standard PA documentation package in South Dakota includes: (a) a letter of medical necessity from the prescribing provider, (b) the patient's documented blood pressure readings or relevant lab values, (c) diagnosis codes (ICD-10: I10 for primary hypertension; I50.x for heart failure; N18.x for CKD), and (d) any contraindication or intolerance documentation if requesting a non-standard agent after lisinopril failure.

The AHA/ACC Hypertension Guideline (2017, updated 2023) defines Stage 2 hypertension as a systolic BP of 140 mmHg or higher or diastolic BP of 90 mmHg or higher, and recommends initiating pharmacotherapy alongside lifestyle modification. That guideline language is routinely cited in PA letters to establish medical necessity. [8]


Generic Lisinopril Cost and Pharmacy Options in South Dakota

Generic lisinopril ranks among the most affordable medications on the U.S. market. A 30-day supply of 10 mg tablets costs $4 at Walmart, $10 at Kroger/Smith's, and between $8 and $15 at most independent pharmacies in South Dakota without insurance. GoodRx coupon pricing in Sioux Falls brings a 30-tablet supply of 10 mg to approximately $4 to $6 at Walgreens or CVS as of early 2025.

Patients without insurance should ask pharmacists specifically about the $4 generic program (Walmart), the WellRx or GoodRx discount cards, or manufacturer patient assistance programs. Because lisinopril is off-patent and produced by dozens of generic manufacturers, supply shortages are uncommon and pricing is stable. The FDA lists no current shortage for lisinopril as of January 2025. [11]

For 90-day mail-order supply, Amazon Pharmacy frequently prices 90 tablets of 20 mg at under $15 with Prime membership, making it one of the lowest-cost delivery options for South Dakota patients in rural areas far from retail chains.


Monitoring After Starting Lisinopril

Starting lisinopril is not a set-and-forget event. The monitoring schedule below reflects the 2023 AHA/ACC Hypertension Guideline recommendations and standard nephrology practice. [8]

At 2 to 4 weeks: Repeat BMP. Confirm potassium remains below 5.5 mEq/L and creatinine has not risen more than 30% from baseline. Blood pressure re-check, either via telehealth cuff reading submission or in-office visit.

At 3 months: Full BMP repeat. Blood pressure target assessment. For patients with diabetes or CKD: urine albumin-to-creatinine ratio.

Annually: BMP, blood pressure review, medication reconciliation. Screen for new contraindications (pregnancy, bilateral renal artery stenosis, concomitant ARB use).

Dry cough, the most common side effect of ACE inhibitors, occurs in 5% to 20% of patients and is mediated by bradykinin accumulation. [12] It is not dangerous but is a frequent reason for switching to an angiotensin receptor blocker (ARB) such as losartan. Angioedema, a rare but serious complication, occurs in 0.1% to 0.7% of patients and requires immediate discontinuation and emergency evaluation. Black patients have a two- to four-fold higher incidence of ACE-inhibitor-induced angioedema compared with white patients, per pharmacovigilance data from the FDA Adverse Event Reporting System. [13]

Patients should be counseled to hold lisinopril and contact their provider if they develop any facial swelling, tongue swelling, or difficulty breathing within hours to days of initiating or increasing the dose.


South Dakota-Specific Access Considerations

South Dakota's geography creates real access challenges. The state spans 77,116 square miles with a 2023 population of approximately 909,000, giving it one of the lowest population densities in the contiguous United States. Many rural counties have fewer than one primary care physician per 3,500 residents according to the HRSA Health Workforce data. [14]

Telehealth closees that gap substantially. A patient in Bennett County (population roughly 3,400, nearest town Martin) can complete a video visit with a Sioux Falls-based NP and receive a lisinopril prescription shipped to the Martin post office within three to four business days, with no driving required.

South Dakota does not impose telemedicine parity laws that mandate commercial insurers reimburse telehealth at the same rate as in-person visits for all services. As of 2024, the state mandates parity only for certain behavioral health services. For hypertension management via telehealth, reimbursement rates vary by payer. Patients using cash-pay telehealth platforms typically pay $50 to $100 for an initial hypertension consultation, with follow-up visits at $20 to $50.

One practical advantage for South Dakota patients: the state has no state income tax and no prescription drug sales tax, meaning the retail price of generic lisinopril is the full cost. There are no hidden state levies added at the pharmacy counter.


Frequently asked questions

How do I get a lisinopril prescription in South Dakota?
Book a visit with a South Dakota-licensed provider, either in-person at a clinic or via a licensed telehealth platform. The provider will review your blood pressure readings and medical history, order a basic metabolic panel if you don't have recent lab results, and send an electronic prescription to your preferred pharmacy. Most patients complete the process in 2 to 5 business days.
What labs are needed before lisinopril in South Dakota?
A basic metabolic panel (BMP) covering serum creatinine, eGFR, potassium, and sodium is required before starting. Women of reproductive age also need a pregnancy test. A repeat BMP at 2 to 4 weeks after starting is standard practice to confirm kidney function and potassium remain stable.
Are there telehealth providers in South Dakota prescribing lisinopril?
Yes. South Dakota authorizes telehealth prescribing of non-controlled medications like lisinopril. Any MD, DO, NP, or PA holding a valid South Dakota license may prescribe via synchronous video or telephone visit. Multiple national telehealth platforms serve South Dakota residents statewide.
How long until I receive lisinopril in South Dakota?
With recent lab work in hand, most patients receive their prescription within 24 to 48 hours of completing a telehealth visit. Retail pharmacies in Sioux Falls, Rapid City, and other towns fill same-day or next-day. Mail-order delivery to any South Dakota ZIP code takes 2 to 4 business days with standard shipping.
Can I transfer a lisinopril prescription to South Dakota?
Yes. Lisinopril is not a controlled substance, so South Dakota pharmacy law allows transfer of remaining refills from any licensed out-of-state pharmacy to a South Dakota pharmacy. Contact the receiving pharmacy with the originating pharmacy's name and phone number. Cross-chain transfers typically complete within one business day.
Are 503A pharmacies in South Dakota licensed to ship lisinopril?
Yes, with conditions. A 503A compounding pharmacy may prepare lisinopril in an alternative dose form (such as oral suspension) for a specific patient when a commercially available tablet is not suitable. The FDA does not permit compounding of commercially available tablet strengths simply to substitute for manufactured product. Verify the pharmacy holds an active South Dakota non-resident pharmacy license.
Who can prescribe lisinopril in South Dakota: MD vs NP vs PA?
All three may prescribe lisinopril. MDs and DOs hold full independent authority. NPs in South Dakota have held full practice authority since 2021 and may prescribe all non-controlled medications independently. PAs prescribe under a delegated authority agreement with a supervising SD-licensed physician, which routinely covers all non-controlled drugs including lisinopril.
What documentation does prior authorization require in South Dakota?
Generic lisinopril rarely requires prior authorization because it is Tier 1 on most commercial formularies. When PA is required (usually for above-label doses or brand-name agents), the standard package includes a letter of medical necessity, documented blood pressure readings, ICD-10 diagnosis codes (I10, I50.x, or N18.x), and any documentation of contraindications to alternatives.
Does South Dakota Medicaid cover lisinopril?
No. South Dakota Medicaid does not currently cover lisinopril for hypertension, heart failure, or CKD indications as of 2025. Patients on Medicaid should ask their pharmacist about $4 generic programs at Walmart, GoodRx discount cards, or manufacturer patient assistance options, which can reduce the out-of-pocket cost to under $10 per month.
What is the usual starting dose of lisinopril for high blood pressure?
The FDA-approved starting dose for hypertension in adults is 10 mg once daily. The dose may be titrated up to 40 mg once daily based on blood pressure response at intervals of 2 to 4 weeks. Patients with renal impairment or who are on diuretics typically start at 5 mg once daily.
Can I get lisinopril without insurance in South Dakota?
Yes. Generic lisinopril costs $4 per month at Walmart's $4 generic program and $4 to $6 with GoodRx at major chains. No insurance is required. Cash-pay telehealth consultations for hypertension management typically cost $50 to $100 for the initial visit, making the total first-month cost under $110 without any insurance.

References

  1. U.S. Food and Drug Administration. Lisinopril tablets prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/019777s057lbl.pdf
  2. ALLHAT Officers and Coordinators. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic. JAMA. 2002;288(23):2981-2997. https://pubmed.ncbi.nlm.nih.gov/12479763/
  3. Ruggenenti P, Perna A, Loriga G, et al. Blood-pressure control for renoprotection in patients with non-diabetic chronic renal disease (REIN-2). Lancet. 2005;365(9463):939-946. https://pubmed.ncbi.nlm.nih.gov/15752709/
  4. Centers for Disease Control and Prevention. Ambulatory care drug database. https://www.cdc.gov/nchs/ahcd/index.htm
  5. Totten AM, Womack DM, Eden KB, et al. Telehealth: mapping the evidence for patient outcomes from systematic reviews. AHRQ Technical Brief. 2016. https://pubmed.ncbi.nlm.nih.gov/27536752/
  6. Bakris GL, Weir MR. Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine. Arch Intern Med. 2000;160(5):685-693. https://pubmed.ncbi.nlm.nih.gov/10724055/
  7. Palmer BF. Managing hyperkalemia caused by inhibitors of the renin-angiotensin-aldosterone system. N Engl J Med. 2004;351(6):585-592. https://pubmed.ncbi.nlm.nih.gov/15295051/
  8. Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA High Blood Pressure Clinical Practice Guideline. Hypertension. 2018;71(6):e13-e115. https://www.ahajournals.org/doi/10.1161/HYP.0000000000000065
  9. South Dakota Legislature. SDCL 36-11: Pharmacists and Pharmacies. https://sdlegislature.gov/Statutes/36-11
  10. U.S. Food and Drug Administration. 503A compounding pharmacies guidance. https://www.fda.gov/drugs/human-drug-compounding/registered-outsourcing-facilities
  11. U.S. Food and Drug Administration. Current drug shortages. https://www.accessdata.fda.gov/scripts/drugshortages/
  12. Israili ZH, Hall WD. Cough and angioneurotic edema associated with angiotensin-converting enzyme inhibitor therapy. Ann Intern Med. 1992;117(3):234-242. https://pubmed.ncbi.nlm.nih.gov/1616218/
  13. U.S. Food and Drug Administration. FDA Adverse Event Reporting System (FAERS). https://www.fda.gov/drugs/questions-and-answers-fdas-adverse-event-reporting-system-faers
  14. Health Resources and Services Administration. Area Health Resources Files. https://data.hrsa.gov/